Wang Zixing, Han Wei, Zhang Weiwei, Xue Fang, Wang Yuyan, Hu Yaoda, Wang Lei, Zhou Chunwu, Huang Yao, Zhao Shijun, Song Wei, Sui Xin, Shi Ruihong, Jiang Jingmei
Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing, 100005, P. R. China.
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, 100021, P. R. China.
Chin J Cancer. 2017 Jul 14;36(1):57. doi: 10.1186/s40880-017-0221-8.
Mortality outcomes in trials of low-dose computed tomography (CT) screening for lung cancer are inconsistent. This study aimed to evaluate whether CT screening in urban areas of China could reduce lung cancer mortality and to investigate the factors that associate with the screening effect.
A decision tree model with three scenarios (low-dose CT screening, chest X-ray screening, and no screening) was developed to compare screening results in a simulated Chinese urban cohort (100,000 smokers aged 45-80 years). Data of participant characteristics were obtained from national registries and epidemiological surveys for estimating lung cancer prevalence. The selection of other tree variables such as sensitivities and specificities of low-dose CT and chest X-ray screening were based on literature research. Differences in lung cancer mortality (primary outcome), false diagnoses, and deaths due to false diagnosis were calculated. Sensitivity analyses were performed to identify the factors that associate with the screening results and to ascertain worst and optimal screening effects considering possible ranges of the variables.
Among the 100,000 subjects, there were 448, 541, and 591 lung cancer deaths in the low-dose CT, chest X-ray, and no screening scenarios, respectively (17.2% reduction in low-dose CT screening over chest X-ray screening and 24.2% over no screening). The costs of the two screening scenarios were 9387 and 2497 false diagnoses and 7 and 2 deaths due to false diagnosis among the 100,000 persons, respectively. The factors that most influenced death reduction with low-dose CT screening over no screening were lung cancer prevalence in the screened cohort, low-dose CT sensitivity, and proportion of early-stage cancers among low-dose CT detected lung cancers. Considering all possibilities, reduction in deaths (relative numbers) with low-dose CT screening in the worst and optimal cases were 16 (5.4%) and 288 (40.2%) over no screening, respectively.
In terms of mortality outcomes, our findings favor conducting low-dose CT screening in urban China. However, approaches to reducing false diagnoses and optimizing important screening conditions such as enrollment criteria for screening are highly needed.
低剂量计算机断层扫描(CT)肺癌筛查试验中的死亡率结果并不一致。本研究旨在评估中国城市地区的CT筛查是否能降低肺癌死亡率,并调查与筛查效果相关的因素。
建立了一个具有三种情景(低剂量CT筛查、胸部X线筛查和不筛查)的决策树模型,以比较模拟的中国城市队列(10万名年龄在45 - 80岁的吸烟者)中的筛查结果。参与者特征数据来自国家登记处和流行病学调查,用于估计肺癌患病率。其他树状变量的选择,如低剂量CT和胸部X线筛查的敏感性和特异性,基于文献研究。计算肺癌死亡率(主要结局)、假诊断以及因假诊断导致的死亡的差异。进行敏感性分析,以确定与筛查结果相关的因素,并考虑变量的可能范围确定最差和最佳筛查效果。
在10万名受试者中,低剂量CT筛查、胸部X线筛查和不筛查情景下的肺癌死亡人数分别为448、541和591例(低剂量CT筛查比胸部X线筛查降低17.2%,比不筛查降低24.2%)。在10万人中,两种筛查情景下的假诊断成本分别为9387例和2497例,因假诊断导致的死亡分别为7例和2例。与不筛查相比,对低剂量CT筛查降低死亡影响最大的因素是筛查队列中的肺癌患病率、低剂量CT敏感性以及低剂量CT检测出的肺癌中早期癌症的比例。考虑所有可能性,在最差和最佳情况下,低剂量CT筛查与不筛查相比减少的死亡人数(相对数)分别为16例(5.4%)和288例(40.2%)。
就死亡率结果而言,我们的研究结果支持在中国城市地区进行低剂量CT筛查。然而,迫切需要减少假诊断以及优化重要筛查条件(如筛查入选标准)的方法。